---
$id: https://graph.org.ai/products/commodity/51131507
$type: Product
source: UNSPSC
code: "51131507"
title: "Darbepoetin alfa"
class: "51131500"
classTitle: "Antianemic drugs"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Darbepoetin alfa

**UNSPSC Code**: 51131507
**Class**: [Antianemic drugs](Antianemic drugs.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a gnas gene with the molecular formula C800H1300N228O24S5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 15UQ94PT4P, more generally known as darbepoetin alfa. European Medicines Agency schedules darbepoetin alfa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12486MIG. The term DARBEPOETIN ALFA is an International Non-Proprietary Name or INN. Most nations schedule darbepoetin alfa under HS 30021095 and SITC 54163. As of Q4 2014, DARBEPOETIN ALFA remains the US FDA Preferred Term for this commodity. Darbepoetin alfa bears US NLM identifiers UMLS ID C0937950 and NCI Concept Code C1878. SMILES: NONE.

